Safety and Efficacy of Combining nbUVB to Etanercept in Patients
Study Description:
This study will provide data on the addition of nbUVB phototherapy to patients who have not shown an excellent response to three months of etanercept.
Maladies et affections de la peau:
Psoriasis
Study Start Date:
avril 2008
Estimated completion date:
août 2009
Study Location(s):
Laval
Province:
Quebec
Agegroup:
18+ years
Gender:
Both
Healthy Volunteers:
No
Study Director/Investigator:
Robert Bissonnette, MD
Pour nous joindre:
Pierre Lebeau (514) 521-3111 ext 233
Contact Information:
Canadian Skin Patient Alliance
2446 Bank Street, Suite 383
Ottawa, Ontario
K1V 1A8
Christine Jackson, Executive Director
phone: 613-422-4265
fax: 613-422- 4267



